美罗华联合化疗在NHL合并乙肝患者中的应用体会幻灯片.pptVIP

美罗华联合化疗在NHL合并乙肝患者中的应用体会;问题;乙肝流行病学;乙肝或丙肝患者增加肿瘤风险;亚洲 N HBsAg阳性率 分型 Markovic 222 12.6% 76%BC Kuniyoshi 126 13.7% 74%BC Kim 187 14.6% 松山 348 21.4% 80%BC;淋巴瘤合并HBV感染患者化疗后的肝损害加重;免疫化疗可激活HBV;为什么会再激活?;国内经验分享;FDA Oct 9,2004 Carriers of hepatitis B should be closely monitored for clinical and laboratory signs of active HBV infection and for signs of hepatitis during and up to one year following rituximab therapy. FDA Dec18,2006 Hepatitis B reactivation Rituxan can cause the virus to become active, causing liver damage and even death. ;提前预防用药的重要性;抗病毒治疗的药???;治疗共识 ;病例介绍;下一步治疗;我们的选择;治疗2周期后;下一步治疗;我们的选择;治疗4周期后;再下一步治疗;我们的选择;小结;致谢